These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11886580)

  • 1. Volunteer donor apheresis.
    Waxman DA
    Ther Apher; 2002 Feb; 6(1):77-81. PubMed ID: 11886580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicomponent donor apheresis in the Americas.
    Waxman DA
    Ther Apher Dial; 2004 Apr; 8(2):93-6. PubMed ID: 15255123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections.
    Yuan S; Gornbein J; Smeltzer B; Ziman AF; Lu Q; Goldfinger D
    Transfusion; 2008 Jun; 48(6):1213-9. PubMed ID: 18346014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of apheresis donation.
    Sniecinski IJ
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():52-6. PubMed ID: 3679530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental findings of the 2019 National Blood Collection and Utilization Survey.
    Mowla SJ; Sapiano MRP; Jones JM; Berger JJ; Basavaraju SV
    Transfusion; 2021 Sep; 61 Suppl 2(Suppl 2):S11-S35. PubMed ID: 34337759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
    Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
    Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
    Vamvakas EC
    Transfusion; 2009 Dec; 49(12):2743-58. PubMed ID: 19682339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matching blood donations to type-specific product needs: a recruitment technique.
    Kuriyan M; Wells S
    J Clin Apher; 1995; 10(1):23-6. PubMed ID: 7601863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
    Macher S; Sipurzynski-Budraβ S; Rosskopf K; Semmelrock M; Prüller F; Griesbacher A; Lanzer G; Schallmoser K
    Vox Sang; 2012 Oct; 103(3):194-200. PubMed ID: 22471611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
    Strauss RG
    J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC-reduced RBC apheresis concentrates.
    Moog R; Franck V; Pierce JA; Müller N
    Transfusion; 2001 Sep; 41(9):1159-64. PubMed ID: 11552075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of donor apheresis.
    Winters JL
    J Clin Apher; 2006 Jul; 21(2):132-41. PubMed ID: 15880355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil.
    Blatyta PF; Custer B; Liu J; Mendrone-Junior A; Wright DJ; Leão SC; Lopes MI; Carneiro-Proietti AB; Sabino EC; de Almeida-Neto C;
    Transfus Apher Sci; 2013 Feb; 48(1):15-20. PubMed ID: 22985535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data on apheresis, blood collection, and transfusion-related activities: statistical analyses of the American Association of Blood Banks institutional membership questionnaires.
    Devine P; Goldstein R; Linden JV; Postoway N; Hoffstadter LK; Hines DM
    Transfusion; 1996 Apr; 36(4):375-81. PubMed ID: 8623142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.